Amplification of Plasmodium falciparum multidrug resistance gene 1 in isolates from Gabon

57Citations
Citations of this article
59Readers
Mendeley users who have this article in their library.

Abstract

The study of molecular markers of drug resistance is particularly important in surveillance studies of drugs, such as mefloquine, that still retain efficacy in sub-Saharan Africa yet have encountered resistance elsewhere. In a recent study in Thailand, we identified amplification of the Plasmodium falciparum multidrug resistance gene 1 (pfmdr1) as being the most important predictor of in vitro drug resistance and in vivo failure of mefloquine monotherapy. Here we report amplification of pfmdr1 in >5% of patient samples from Lambaréné, Gabon, collected in 1995. None of the samples collected 7 years later showed pfmdr1 amplification, suggesting that parasites with increased numbers of pfmdr1 copies have not substantially spread through the population. Nevertheless, the detection of multicopy pfmdr1 in African parasites suggests a high potential for rapid selection for resistance, implying that mefloquine use in Africa should be considered only as part of combination therapy. © 2005 by the Infectious Diseases Society of America. All rights reserved.

Cite

CITATION STYLE

APA

Uhlemann, A. C., Ramharter, M., Lell, B., Kremsner, P. G., & Krishna, S. (2005). Amplification of Plasmodium falciparum multidrug resistance gene 1 in isolates from Gabon. Journal of Infectious Diseases, 192(10), 1830–1835. https://doi.org/10.1086/497337

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free